Ac-(HHPHG)4 -NH2

General Information


DRACP ID  DRACP00111

Peptide Name   Ac-(HHPHG)4 -NH2

Sequence  HHPHGHHPHGHHPHGHHPHG

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Cancer targeted peptides Antiangiogenic



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
3LL Lewis lung carcinoma Carcinoma The 50 mg/kg dose in the 3LL model significantly inhibited tumor growth by 48% Syngeneic tumor models Not available 1
B16-F1 Mouse melanoma Carcinoma The 50 mg/kg dose in the 3LL model significantly inhibited tumor growth by 48% Syngeneic tumor models Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Tropomyosin

Affinity  Not available

Mechanism  Bind to Tropomyosin and Have Antiangiogenic and Antitumor Activities

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00111

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C100H126N44O21

Absent amino acids  ACDEFIKLMNQRSTVWY

Common amino acids  H

Mass  261948

Pl  8.15

Basic residues  12

Acidic residues  0

Hydrophobic residues  0

Net charge  12

Boman Index  -5216

Hydrophobicity  -232

Aliphatic Index  0

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 15313924

Title  Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities

Doi 10.1158/0008-5472.CAN-04-0440

Year  2004

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.